182 related articles for article (PubMed ID: 31822802)
1. Diagnostic utility of STAT6
Van Slambrouck C; Huh J; Suh C; Song JY; Menon MP; Sohani AR; Duffield AS; Goldberg RC; Dama P; Kiyotani K; Godfrey J; Fitzpatrick C; Kline J; Smith SM; Jaffe ES; Hartmann S; Venkataraman G
Mod Pathol; 2020 May; 33(5):834-845. PubMed ID: 31822802
[TBL] [Abstract][Full Text] [Related]
2. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
3. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
4. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
5. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Tian X; Xu J; Dorfman DM
Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
[TBL] [Abstract][Full Text] [Related]
6. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Churchill HR; Roncador G; Warnke RA; Natkunam Y
Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.
Alikhan M; Song JY; Sohani AR; Moroch J; Plonquet A; Duffield AS; Borowitz MJ; Jiang L; Bueso-Ramos C; Inamdar K; Menon MP; Gurbuxani S; Chan E; Smith SM; Nicolae A; Jaffe ES; Gaulard P; Venkataraman G
Mod Pathol; 2016 Oct; 29(10):1173-82. PubMed ID: 27312067
[TBL] [Abstract][Full Text] [Related]
9. TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas.
Rodig SJ; Savage KJ; Nguyen V; Pinkus GS; Shipp MA; Aster JC; Kutok JL
Am J Surg Pathol; 2005 Feb; 29(2):196-203. PubMed ID: 15644776
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls in diagnostic hematopathology -- Part II.
Zhao XF
Int J Clin Exp Pathol; 2009 Sep; 3(1):39-46. PubMed ID: 19918327
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas.
Kondratiev S; Duraisamy S; Unitt CL; Green MR; Pinkus GS; Shipp MA; Kutok JL; Drapkin RI; Rodig SJ
Am J Surg Pathol; 2011 Oct; 35(10):1531-9. PubMed ID: 21921781
[TBL] [Abstract][Full Text] [Related]
12. Utility of LRF/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma.
Bohn O; Maeda T; Filatov A; Lunardi A; Pandolfi PP; Teruya-Feldstein J
Int J Surg Pathol; 2014 Feb; 22(1):6-11. PubMed ID: 24326827
[TBL] [Abstract][Full Text] [Related]
13. Glioma-associated oncogene homologue 3, a hedgehog transcription factor, is highly expressed in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Greaves WO; Kim JE; Singh RR; Drakos E; Kunkalla K; Sánchez-Espiridión B; Garcia JF; Medeiros LJ; Vega F
Hum Pathol; 2011 Nov; 42(11):1643-52. PubMed ID: 21531006
[TBL] [Abstract][Full Text] [Related]
14. A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma.
Ally F; Gajzer D; Fromm JR
Clin Lab Med; 2023 Sep; 43(3):427-444. PubMed ID: 37481321
[TBL] [Abstract][Full Text] [Related]
15. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
[TBL] [Abstract][Full Text] [Related]
17. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.
Desouki MM; Post GR; Cherry D; Lazarchick J
Clin Med Res; 2010 Jul; 8(2):84-8. PubMed ID: 20660931
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.
Chen BJ; Chapuy B; Ouyang J; Sun HH; Roemer MG; Xu ML; Yu H; Fletcher CD; Freeman GJ; Shipp MA; Rodig SJ
Clin Cancer Res; 2013 Jul; 19(13):3462-73. PubMed ID: 23674495
[TBL] [Abstract][Full Text] [Related]
19. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.
Iwaki N; Sato Y; Kurokawa T; Maeda Y; Ohno K; Takeuchi M; Takata K; Orita Y; Nakao S; Yoshino T
Med Mol Morphol; 2013 Sep; 46(3):172-6. PubMed ID: 23512149
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]